Distinct Mechanisms Lead to HPRT Gene Mutations in Leukemic Cells

Genes Chromosomes and Cancer

Volumn 39, Issue 4, 2004, Pages 311-323

  Lin, Ying Wei ^a,b   Perkins, Jonathan J ^a   Zhang, Zhenhua ^a   Aplan, Peter O ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MUTATION; HEMATOPOIETIC CELL; HPRT GENE; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL LINE; LYMPHOBLASTOID CELL LINE; MALE; MALIGNANT TRANSFORMATION; MISMATCH REPAIR; MUTATION RATE; POINT MUTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTES; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC MARKERS; GENOMIC INSTABILITY; HL-60 CELLS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; JURKAT CELLS; K562 CELLS; LEUKEMIA; MALE; MUTAGENESIS; MUTATION; PILOT PROJECTS; RECOMBINATION, GENETIC; RNA SPLICING; RNA, MESSENGER; RNA, NEOPLASM; U937 CELLS;

EID: 1542283689     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20005     Document Type: Article

References (57)

1. Albertini RJ. 2001. HPRT mutations in humans: biomarkers for mechanistic studies. Mutat Res 489:1-16.
2. Albertini RJ, Castle KL, Borcherding WR. 1982. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc Natl Acad Sci USA 79:6617-6621.
3. Baranovskaya S, Soto JL, Perucho M, Malkhosyan SR. 2001. Functional significance of concomitant inactivation of hMLH1 and hMSH6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci USA 98:15107-15112.
4. Boumil RM, Lee JT. 2001. Forty years of decoding the silence in X-chromosome inactivation. Hum Mol Genet 10:2225-2232.
5. Bourguin A, Tung R, Galili N, Sklar J. 1990. Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms. Proc Natl Acad Sci USA 87:8536-8540.
6. Branda RF, Sullivan LM, O'Neill JP, Falta MT, Nicklas JA, Hirsch B, Vacek PM, Albertini RJ. 1993. Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat Res 285:267-279.
7. Burnett RC, David JC, Harden AM, Le Beau MM, Rowley JD, Diaz MO. 1991. The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2. Genes Chromosomes Cancer 3:461-467.
8. Cariello NF. 1994. Database and software for the analysis of mutations at the human hprt gene. Nucleic Acids Res 22:3547-3548.
9. Cox R, Masson WK. 1976. X-ray-induced mutation to 6-thioguanine resistance in cultured human diploid fibroblasts. Mutat Res 37:125-136.
10. de Boer JG, Curry JD, Glickman BW. 1993. A fast and simple method to determine the clonal relationship among human T-cell lymphocytes. Murat Res 288:173-180.
11. DeMars R, Held KR. 1972. The spontaneous azaguanine-resistant mutants of diploid human fibroblasts. Humangenetik 16:87-110.
12. Dietz HC, Kendzior RJ, Jr. 1994. Maintenance of an open reading frame as an additional level of scrutiny during splice site selection. Nat Genet 8:183-188.
13. Elion GB. 1967. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Fed Proc 26: 898-904.
14. Feldmann E, Schmiemann V, Goedecke W, Reichenberger S, Pfeiffer P. 2000. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res 28:2585-2596.
15. Finette BA, Sullivan LM, O'Neill JP, Nicklas JA, Vacek PM, Albertini RJ. 1994. Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Murat Res 308:223-231.
16. Finette BA, Poseno T, Albertini RJ. 1996. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res 56:1405-1412.
17. Finette BA, Homans AC, Albertini RJ. 2000. Emergence of genetic instability in children treated for leukemia. Science 288:514-517.
18. German J. 1997. Bloom's syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet 93:100-106.
19. Gibbs RA, Nguyen PN, Edwards A, Civitello AB, Caskey CT. 1990. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics 7:235-244.
20. Gu L, Cline-Brown B, Zhang F, Qiu L, Li GM. 2002. Mismatch repair deficiency in hematological malignancies with microsatellite instability. Oncogene 21:5758-5764.
21. Hahn WC, Weinberg RA. 2002. Rules for making human tumor cells. N Engl J Med 347:1593-1603.
22. Hershfield MS, Kurtzberg J, Harden E, Moore JO, Whang-Peng J, Haynes BF. 1984. Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2′-deoxycoformycin. Proc Natl Acad Sci USA 81:253-257.
23. Hiraki S, Miyoshi I, Masuji H, Kubonishi I, Matsuda Y. 1977. Establishment of an Epstein-Barr virus- determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia. J Natl Cancer Inst 59:93-94.
24. Humbert O, Hermine T, Hernandez H, Bouget T, Selves J, Laurent G, Salles B, Lautier D. 2002. Implication of protein kinase C in the regulation of DNA mismatch repair protein expression and function. J Biol Chem 277:18061-18068.
25. Iitsuka Y, Bock A, Nguyen DD, Samango-Sprouse CA, Simpson JL, Bischoff FZ. 2001. Evidence of skewed X-chromosome inactivation in 47,XXY and 48,XXYY Klinefelter patients. Am J Med Genet 98:25-31.
26. Jolly DJ, Okayama H, Berg P, Esty AC, Filpula D, Bohlen P, Johnson GG, Shively JE, Hunkapillar T, Friedmann T. 1983. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. Proc Natl Acad Sci USA 80:477-481.
27. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW. 1980. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56:265-273.
28. Lee JY, Lee CH, Shim SH, Seo HK, Kyhm JH, Cho S, Cho YH. 2002. Molecular cytogenetic analysis of the monoblastic cell line U937. karyotype clarification by G-banding, whole chromosome, painting, microdissection and reverse painting, and comparative genomic hybridization. Cancer Genet Cytogenet 137:124-132.
29. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
30. Levati L, Marra G, Lettieri T, D'Atri S, Vernole P, Tentori L, Lacal PM, Pagani E, Bonmassar E, Jiricny J, Graziani G. 1998. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer 23:159-166.
31. Lewis BP, Green RE, Brenner SE. 2003. Evidence for the wide-spread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 100:189-192.
32. Lin YW, Kubota M, Wakazono Y, Hirota H, Okuda A, Bessho R, Usami I, Kataoka A, Yamanaka C, Akiyama Y, Furusho K. 1996. Normal mutation frequencies of somatic cells in patients receiving growth hormone therapy. Mutat Res 362:97-103.
33. Loeb LA. 2001. A mutator phenotype in cancer. Cancer Res 61: 3230-3239.
34. Lozano F, Places L, Alberola-Ila J, Mila M, Villamor N, Barcelo J, Fabregat V, Vives J. 1993. Isolation and characterisation of a CDw50 negative Jurkat T-cell line variant (PPL.1). Leuk Res 17:9-16.
35. MacLeod RA, Dirks WG, Reid YA, Hay RJ, Drexler HG. 1997. Identity of original and late passage Dami megakaryocytes with HEL erythroleukemia cells shown by combined cytogenetics and DNA fingerprinting. Leukemia 11:2032-2038.
36. Malkhosyan S, McCarty A, Sawai H, Perucho M. 1996. Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype. Mutat Res 316:249-259.
37. Maquat LE. 2001. The power of point mutations. Nat Genet 27:5-6.
38. Massaad L, Venuat AM, Remvikos Y, Dutrillaux B. 1990. Revision of the chromosome anomalies of the T-cell malignant cell line peer. Ann Genet 33:76-78.
39. Minowada J, Onuma T, Moore GE. 1972. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst 49:891-895.
40. Moore DE, Weise K, Zawydiwski R, Thompson EB. 1985. The karyotype of the glucocorticoid-sensitive, lymphoblastic human T- cell line CCRF-CEM shows a unique deleted and inverted chromosome 9. Cancer Genet Cytogenet 14:89-94.
41. Mount SM. 1982. A catalogue of splice junction sequences. Nucleic Acids Res 10:459-472.
42. Naumann S, Reutzel D, Speicher M, Decker HJ. 2001. Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization. Leuk Res 25:313-322.
43. O'Neill JP, McGinniss MJ, Berman JK, Sullivan LM, Nicklas JA, Albertini RJ. 1987. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 2:87-94.
44. Otter AR, Thilly WG. 1992. Mutational spectra in human B-cells. Spontaneous, oxygen and hydrogen peroxide-induced mutations at the hprt gene. J Mol Biol 228:813-826.
45. Pai GS, Sprenkle JA, Do TT, Mareni CE, Migeon BR. 1980. Localization of loci for hypoxanthine phosphoribosyltransferase and glucose-6-phosphate dehydrogenase and biochemical evidence of nonrandom X chromosome expression from studies of a human X-autosome translocation. Proc Natl Acad Sci USA 77:2810-2813.
46. Patel PI, Framson PE, Caskey CT, Chinault AC. 1986. Fine structure of the human hypoxanthine phosphoribosyltraasferase gene. Mol Cell Biol 6:393-403.
47. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G. 1983. Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 70:447-453.
48. Renan MJ. 1993. How many mutations are required for tumorigenesis? Implications from human cancer data. Mot Carcinog 7:139-146.
49. Savelyeva L, Mamaeva S. 1988. Population analysis of karyotypic heterogeneity of the Raji Burkitt lymphoma cell line. Analysis of 100 karyotypes. Cancer Genet Cytogenet 34:63-75.
50. Schunemann HJ, Stanulla M, Trevisan M, Aplan PD, Freudenheim JL, Muti P. 2000. Short-term storage of blood samples and DNA isolation in serum separator tubes for application in epidemiological studies and clinical research. Ann Epidemiol 10:538-544.
51. Seegmiller JE, Rosenbloom FM, Kelley WN. 1967. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155:1682-1684.
52. Smith SD, McFall P, Morgan R, Link M, Hecht F, Cleary M, Sklar J. 1989. Long-term growth of malignant thymocytes in vitro. Blood 73:2182-2187.
53. Strout MP, Mrozek K, Heinonen K, Sait SN, Shows TB, Aplan PD. 1996. ML-1 cell line lacks a germline MLL locus. Genes Chromosomes. Cancer 16:204-210.
54. Taverna P, Liu L, Hanson AJ, Monks A, Gerson SL. 2000. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen. Cancer Chemother Pharmacol 46:507-516.
55. Taylor AM, Metcalfe JA, Thick J, Mak YF. 1996. Leukemia and lymphoma in ataxia telangiectasia. Blood 87:423-438.
56. Volpi EV, Vatcheva R, Labella T, Gan SU. 1996. More detailed characterization of some of the HL60 karyotypic features by fluorescence in situ hybridization. Cancer Genet Cytogenet 87:103-106.
57. Yan H, Dobbie Z, Gruber SB, Markowitz S, Romans K, Giardiello FM, Kinzler KW, Vogelstein B. 2002. Small changes in expression affect predisposition to tumorigenesis. Nat Genet 30:25-26.